Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04446312 · ClinicalTrials.gov registry record · Phase 3
Study 302: BLI4900 Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy
A Phase 3 study, sponsored by Braintree Laboratories.
- Completed
- Registry status
- Phase 3
- Development phase
- 500
- Enrollment target
NCT04446312 is a Phase 3 study that has completed, run by Braintree Laboratories. The registered enrollment target is 500 participants.
The verdict
NCT04446312, a Phase 3 study, has completed, sponsored by Braintree Laboratories.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 500 participants
- Enrollment target
Study Summary
The purpose of this study is to compare the safety and efficacy of BLI4900 bowel preparation to an FDA-approved control as 2-day, split-dose bowel preparations prior to colonoscopy in adult patients.
Interventions
- DRUG Bowel Prep
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2020-07-13 |
| Est. Completion | 2021-02-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04446312
The ClinicalTrials.gov registry entry for NCT04446312 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Braintree Laboratories, which has 49 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Bowel Prep is the first listed.
NCT04446312 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04446312 about?
NCT04446312 is a clinical study titled "Study 302: BLI4900 Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy". The purpose of this study is to compare the safety and efficacy of BLI4900 bowel preparation to an FDA-approved control as 2-day, split-dose bowel preparations prior to colonoscopy in adult patients.
What is the current status of trial NCT04446312?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 500 participants. The study started on 2020-07-13. Estimated completion is 2021-02-05.
What interventions are being tested in trial NCT04446312?
The interventions under investigation include: Bowel Prep (DRUG).
Who is sponsoring clinical trial NCT04446312?
This trial is sponsored by Braintree Laboratories, which has 49 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.